2019) 'Reductive stress selectively disrupts collagen homeostasis and modies growth factor-independent signalling through the MAPK/Akt pathway in human dermal broblasts.', Molecular and cellular proteomics., 18 (6).
transmembrane sensors Ire1α and ATF6 to drive the production of compensatory ER chaperones and lipids, facilitating ER expansion. Meanwhile, PERK attenuates general translation while allowing the synthesis of a restricted set of target genes through the phosphorylation of eIF2α (5) . ER stress responses can also feed in to cytosolic receptor mediated signalling pathways. Urano et. al. showed that ER stress can activate the c-Jun amino-terminal kinase (JNK), and that the cytoplasmic tail of IRE1 interacts with TRAF2, a JNK adaptor protein (6) , most likely through ASK1, a MAPK kinase kinase (7) . Thus, MAP kinases are activated by endogenous and exogenous (receptor-driven) signalling.
In addition to inducing an ER stress response, disruption of oxidative protein folding disturbs the redox balance of the cell. Reductants such as DTT can trigger an ER stress response by disrupting disulfide bonds, leading to an accumulation of newly synthesized proteins in the ER (8) . However, little is known about the quantitative response of cells to reductants and how the global cell proteome is affected by the combined effect of redox and ER stress, particularly during metabolically demanding conditions such as proteostasis in response to growth factors. To investigate this question, we have studied the effect of reductive ER stress in human dermal skin fibroblasts subject to stimulation by PDGF. The PDGF pathway in fibroblasts is well understood and is an important contributor to wound healing in the skin.
PDGF stimulates the dimerisation and autophosphorylation of PDGFR family molecules, followed by recruitment of the signal transduction machinery (e.g. GRB2, Src, GAP, PI3 kinase, PLCγ, and NCK), culminating in the activation of STAT transcription factors. Various signalling pathways are initiated, leading to the control of cell growth, proliferation and differentiation (by src, MAPK and PKC pathways); and actin reorganization and cell migration (by the PKC and Akt/PKB pathways) (9) .
Data-independent acquisition (DIA) is a robust and reproducible mass spectrometry method (10) for label-free relative quantification of all detectable analytes within a defined range based on their fragment ion spectra. Purvine et. al. first reported a shotgun strategy to identify peptides after collisioninduced dissociation in parallel on a TOF-MS machine (11) . The feasibility of automating the quantitative analysis of complex peptides was demonstrated by Venable et. al. (12) whilst an MS E approach to simultaneously acquire exact mass values and full-scan information from complex samples at both high and low collision energy was subsequently developed by Plumb et. al. (13) . SWATH TM is a specific DIA method, which was developed by the Abersold laboratory (14) and commercialised by ABSCIEX, that we have used in this study to quantitate the response of human skin-derived (dermal) fibroblasts to reductive stress. In recent years, this methodology has been adopted to quantitate protein interactomes, to develop disease biomarkers, to reveal how organisms respond to stress and to map proteostasis, for example in fibroblasts from individuals with Down syndrome (15) (16) (17) (18) . Here, we use the technology to discover new redox-responsive protein targets that provide insight into how the redox environment could be modulated for medical and cosmetic benefit. by guest on March 20, 2019 http://www.mcponline.org/ Downloaded from 4 We find that in skin fibroblasts, reductants stimulate the chronic dephosphorylation of p42/44 MAPK (ERK1/2) whilst concomitantly inducing the phosphorylation of Akt in a growth factorindependent and redox-specific fashion. DIA proteomics revealed that, remarkably, only 1% of the total identified fibroblast proteome was significantly changed after chronic exposure to DTT. Of the proteins that were altered, all but one was diminished, revealing that ER stress induced by DTT does not result in the upregulation of the pool of secretory pathway clients. Rather, reductive stress destabilizes a select set of proteins that includes collagens, ECM components and MAPK signalling pathway targets.
EXPERIMENTAL PROCEDURES

Chemicals
Standard laboratory chemicals were purchased from Sigma Aldrich unless otherwise stated. LiChrosolv LC-MS chromatography solvents were from VWR.
Antibodies
All primary antibodies for western blotting were purchased from Cell Signalling unless stated otherwise.
Antibodies used were: PathScan® PDGFR Activity Assay Multiplex Western Detection Cocktail II (#5304, 1:2000); Phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204) XP® rabbit mAb (#4370, 1:2000); Phospho-Akt (Ser473) (#9271, 1:1000); Akt (pan) (40D4) mouse mAb (#2920, 1:2000); Phospho-eIF2α (Ser51) rabbit pAb (#9721, 1:1000); PDI mouse mAb RL90 (ab2792, 1:100 for IF, Abcam); β-actin mouse mAb (ab8226, 1:15000, Abcam); collagen type I goat pAb (1310-01, 1:1000 Southern Biotech; raised by immunisation against collagen type I and cross-absorped to remove any reactivity against type II, III, IV, V and VI collagens); collagen type VI rabbit pAb (14853-1-AP, 1:500, Proteintech; raised against the human COL6A2-GST fusion protein catalog number Ag6635). Goat anti-mouse peroxidase (GAMPO), swine anti-rabbit peroxidase (SARPO) and rabbit anti-goat peroxidase (RAGPO)-coupled secondary antibodies for Western blotting were used at 1:3000 and purchased from DAKO (Agilent) (#P0447, #P0217 and #P0449 respectively). Goat anti-mouse Alexa-Fluor® 488-conjugated secondary antibodies were used for immunofluorescence (Invitrogen ThermoFisher). The phospho-antibodies against pPDGFR, pAkt and p44/42 were validated against a PDGF-BB stimulated fibroblast lysate (Supplementary Figure 1 ).
6
times with TBS-Tween. Proteins were visualised with 500 µl enhanced chemiluminescence fluid (Amersham) per membrane and exposed to film (Kodak) prior to development in an X-ray developer machine (XOMAT).
Senescence Associated β Galactosidase Activity assay
Staining for senescence-associated β-galactosidase activity was performed using the Senescence β-Galactosidase Staining Kit from Cell Signalling (9860) according to the manufacturer's instructions.
Briefly, spent media from treated BJ fibroblast cells was removed and cells were washed once with PBS before fixing in a proprietary fixative solution for 10-15 min at room temperature. Cells were then washed a further two times before application of pH-adjusted β-galactosidase staining solution and incubated overnight in a dry incubator at 37 °C. Staining solution was then removed, and cells washed twice with PBS. Following staining, dishes of stained cells were either stored in glycerol at 4 °C or immediately DAPI stained and cover slips mounted on microscope slides for analysis. Images were taken using a CMEX WiFi 5 camera (Euromex, DC.5000-WIFI) attached to an inverted wide field fluorescence microscope for analysis of DAPI stained cells (Zeiss Apotome).
Wound closure assay
The wound closure assay was performed according to the method of Liang et al (19) . BJ fibroblasts were seeded onto 6-well plates (Greiner) which had been pre-treated with 10 µg ml -1 fibronectin (Sigma) and grown to confluency. Cells were serum starved for 24 h and the bottom of each well was scratched with a pipette tip (0.2 ml) to create a linear wound area free of cells. After washing twice with PBS (Gibco) the cells were incubated in 10 ng ml -1 PDGF supplemented culture media +/-5 mM DTT (Sigma). After 10 min, the cells were washed and fresh SFM containing 10 ng ml -1 PDGF was added. Cell migration was recorded with an automated Zeiss Cell Observer for 12 h with images taken every 30 min. The cells were kept at 37 o C and 5% CO 2 during image capture. Cell viability was confirmed by monitoring cell movement. Migration into the wound site was quantified by counting how many cells passed the scratch point after 10 h; and by calculating the percentage of cells in the field of view that had passed the scratch point after 10 h. A 1-way ANOVA with a Dunnett's multiple comparison test was conducted in Prism 8 to assess statistical significance (mean ± SD, n=3).
Immunofluorescence
Cells for analysis by immunofluorescence were seeded onto coverslips in 6 cm dishes before treatment.
Treatments were performed once cells had reached ~80% confluence, after which the cells were washed twice with PBS containing 1 mM CaCl 2 and 0.5 mM MgCl 2 (PBS ++ ). Cells were fixed for 10 min in 4% by guest on March 20, 2019 http://www.mcponline.org/ Downloaded from 7 paraformaldehyde, washed in PBS ++ , permeabilised using 0.1% Triton X-100 for 10 min, washed once for 5 min with PBS ++ and blocked with 2% BSA for 1 h at room temperature. Coverslips were incubated with the anti-PDI antibody RL90 at 1:100 dilution in PBS ++ /0.2% BSA overnight at 4 o C. The cells were washed in PBS ++ and then incubated with Alexa-Fluor® 488-conjugated secondary antibody (Invitrogen ThermoFisher) for 1 h at room temperature. The cells were washed three times in PBS ++ and stained with DAPI to visualise nuclei (Sigma). The immunofluorescence images were captured with a brightfield fluorescence microscope (Zeiss Axio Imager M1).
RT-PCR and XBP1 assay
Cells (~10 6 in a 25 cm 2 flask) at ~90% confluence were subjected to a 1 h or 6 h stress with 5 mM DTT in the presence or absence of 10 ng ml -1 PDGF stimulation for 24 h. Cells were washed twice in PBS, lysed in 300 µl TRI reagent and RNA extracted with 50 µl chloroform. RNA content was measured using an ND-1000 spectrophotometer (Nanodrop® Technologies Inc) and 50 ng RNA was subjected to RT-PCR, 
RESULTS
DTT induces ER stress in fibroblasts in the presence or absence of PDGF
PDGF proteins occur as a family of disulfide-bonded, dimeric isoforms (PDGF-AA, AB, BB, CC and DD). For our experiments, we stimulated cells with PDGF-BB, since this isoform binds to PDGFRαβ, αα and αβ receptor combinations (22) . Furthermore, PDGF-BB is known from the literature to stimulate the fibroblasts used in this study, and exogenous PDGF-BB is effective in promoting wound healing in vitro and in ameliorating wound healing disorders in vivo (23) (24) . Initial experiments confirmed that the application of PDGF-BB to serum-starved cultured skin fibroblasts resulted in the transient phosphorylation (within 10 min) of PDGFRβ at Tyr751, at the docking site for PI3 kinase ( Figure 1A,  9 upper panel). PDGF-BB also resulted in a rapid increase in the phosphorylation of ERK1/2 (p44/p42) at Thr202/Tyr204 ( Figure 1A , middle panel), indicating that a signalling response was initiated upon growth factor exposure. An antibody against eIF4E was used as a loading/blotting control ( Figure 1A , lower panel).
PDGF stimulates cell growth and proliferation and therefore may place demands on the oxidative protein folding machinery in the ER. To assess whether long-term (24 h) PDGF stimulation caused an ER stress response or altered the effects of DTT treatment, fibroblasts were serum-starved +/-PDGF stimulation +/-DTT for 1 h or 6 h and assayed for the activation of the ER stress marker XBP1 (25) . We took advantage of a unique Pst1 restriction site within the intron of XBP1 to differentiate between unspliced (inactive) and spliced (active) forms of XBP1 by RT-PCR ( Figure 1B ). RT-PCR products were digested for 2 h with Pst1 before analysis on 2% agarose gel. Cells were exposed to a total of 24 h PDGF-BB, with DTT (when present) being added 1 or 6 h before the end of this time to allow an initial response to PDGF stimulation that was uninhibited by the addition of DTT. In fibroblasts subjected to DTT for 1 h or 6 h, a single ~100 bp band was seen, indicative of an ER stress response ( Figure 1C , lanes 3-6). In the absence of DTT, ER stress was not induced ( Figure 1C Figure 1E ). Furthermore, cells subjected to DTT, PDGF, and DTT and PDGF combined remained viable and adherent, as judged by immunofluorescence analysis of cells with the ER resident protein PDI and the nuclear marker DAPI ( Figure 2 ).
DIA quantitative proteomic analysis of reductively stressed fibroblasts
Having demonstrated that DTT treatment induces an unfolded protein response in viable cells that is independent of PDGFR growth factor signalling, we sought to analyse and relatively quantitate the response of the fibroblast proteome to reductive stress, in a label free and unbiased manner. replicates. This provides a measure of the variance in the quantified values as a percentage of the mean.
An average of 76.8% identifications were found to have %CV ≤ 20% and 89.4% identifications had %CV ≤ 30% to account for the increased variability expected in biological replicates (Supplementary Figure 2) .
The 41 proteins identified as decreasing in the two groups overlapped almost completely; however, in most cases, treatment with PDGF in addition to DTT slightly reduced the fold change, indicating that PDGF had a mild dampening effect on the outcome of DTT exposure. There was an additional set of 17
proteins that significantly declined >2-fold only in the presence of DTT alone, including the plasma membrane recycling receptor CMTM6, the matrix metalloprotease regulator RECK, the serine protease inhibitor and regulator of cell migration SERPINE1, and regulators of the insulin growth factor pathway (IGF2 and MXRA8). The fold changes in global expression of statistically significant proteins that decreased with DTT alone (versus DTT and PDGF treatment) are compared in a heat map ( Figure 4A ).
The GO terms annotated to the proteins identified as significantly changing in response to DTT treatment were next tested for statistical overrepresentation using the Panther overrepresentation test ( Figure 4B ). Regulation of ERK1/2 and MAPK were overrepresented in the significantly changing proteins from DTT treatment, both with and without PDGF. This reveals that proteins involved in ERK1/2 regulation are disproportionately downregulated compared to the total quantifiable proteome detected in this study. ERK1/2 (p44/42) are MAP kinases that are activated by growth factors, and promote cell proliferation, cell survival and migration. In DTT treated cells, with and without PDGF, the proteins annotated to this term were CYR61, NOTCH2, CTGF, TIMP3 and FBLN1. CYR61 has been linked to induction of the ERK1/2 cascade in osteosarcoma cells undergoing epithelial to mesenchymal transition (EMT) (27) ; inactivation of ERK1/2 inhibited the Jagged/Notch signalling pathway in lens epithelial cells (28) ; and ERK1/2 signalling was shown to upregulate CTGF in the mediation of myocardial fibrosis (29) .
Since an increase in ERK1/2 signalling is associated with the increase in expression of these proteins in the cited literature, we reasoned that downregulation of these proteins would be associated with a decrease or perturbation in ERK1/2 (MAPK) signalling. The ERK1/2 scaffold proteins paxillin (PXN), flotillin-1 (FLOT1), MEK binding partner 1 (MP1) and Ras GTPase-activating-like protein IQGAP1 were identified in the data, however the relative levels of these proteins did not change significantly with treatment (Supplementary data). This suggests that any differences in ERK1/2 signalling are unlikely to have been mediated by scaffold protein abundance.
Reducing conditions induce the long-term de-phosphorylation of MAPK p42/44
To confirm the quantitative DIA analysis and to test the hypothesis that reductants lead to alterations in MAPK signalling pathways, we combined PDGF stimulation with DTT treatment for 1 h or 6 h as before ( Figure 5A ) and analysed the protein lysates for the induction of phosphorylated p44/42
(ERK1/2) and phosphorylated Akt by western blot ( Figure 5B ). Akt is a PDGF stimulated signalling molecule that regulates cell proliferation and survival downstream of ERK1/2. Figure 5B shows that a chronic 6 h reductive stress was sufficient to downregulate phosphorylation of ERK1/2 at Thr202/Tyr204, both with or without PDGF stimulation ( Figure 5B , first panel, lanes 5 and 6). Concurrently, Akt phosphorylation at Ser473 was promoted, even in the absence of PDGF ( Figure 5B, second 
DTT induces chronic Akt phosphorylation that can be prevented by the Akt inhibitor perifosine
To further understand the flux through MAPK/Akt that occurs in response to DTT, a time-course was performed, gathering lysates from time-points between 10 min and 6 h after DTT application, in the absence of PDGF stimulation. ERK1/2 phosphorylation was initially stimulated above background by DTT at 10 min, but was gradually attenuated, with a noticeable decline first seen by 4 h (Figure 6A Perifosine treatment did not affect cell proliferation, either with or without DTT, as measured by a cell proliferation assay ( Figure 6C ) and did not enhance cell death or senescence, as judged by a senescence associated βGal assay ( Supplementary Figure 3) . This suggests that, unlike perifosine anti-cancer combination therapies (30), DTT does not synergise with perifosine to promote cell death of skin fibroblasts. Taken together, the data imply that mild reductive stress may, in fact, stimulate a pro-survival MAPK/Akt signalling response.
To test the hypothesis that transient stimulation with reductants can simulate cell migration, we performed a cellular scratch-wound assay ( Supplementary Figure 4) . PDGF stimulated fibroblasts were assessed for their ability to migrate into a wound site with or without a pulse of DTT. After a DTT pulse, 62% cells migrated after 10 hours post-wounding, whereas only 45% of cells migrated in the absence of DTT. This result demonstrates that an acute reductive stimulus can promote biological outcomes downstream of ERK signalling pathways.
A range of reductants and antioxidants modulate receptor-independent p-44/42 and Akt phosphorylation
To establish whether signal transduction through the MAPK/Akt pathway was specifically influenced by DTT, or was generally sensitive to redox perturbations, the effects of taurine and thioglycolate were investigated. The β-amino acid taurine, also known as 2-aminoethanesulfonic acid, is a potent anti-oxidant that occurs naturally during methionine and cysteine metabolism. It is involved in detoxification (31)(32) and has anti-fibrotic properties that have led to its use in cosmetics and anti-ageing creams. Thioglycolate is present in many depilatory products used for cosmetic hair removal and reduces disulfide bonds in keratins to weaken hair structure (33) . Peroxide was used as a control to induce oxidative stress, as H 2 O 2 has previously been shown to induce Akt phosphorylation (34) . Figure 6A with Figure 7B and 7C). Taken together, these findings demonstrate that growth-factor independent signalling through the MAPK pathway is induced by a range of reducing and oxidising agents, with some temporal differences in dynamics that may be dependent on effective concentration or reduction potential.
Collagen homeostasis is selectively perturbed by DTT
Having uncovered novel signalling events in skin fibroblasts in response to reductants from the DIA proteomic analysis, we further explored the long-term consequences of reductive stress for the global proteome. Several GO terms overrepresented in the DTT responding protein dataset ( Figure 4B significance. These identifications were also made from a substantial number of peptide matches suggesting a high level of confidence (Supplementary Figure 5 ; Table 1 ). The relative decrease in the detection of collagen proteins is unlikely to be explained by changes in peptide mass (e.g. hydroxylation at proline residues) because this is internally controlled for in the DIA reference peptide database. Decreased expression of collagen after reductive stress was confirmed by immunoblotting lysates from cells, independently treated +/-DTT, for collagen 1 chains and collagen α2 (VI), with β-actin used as a loading/transfer control ( Figure 8B ). The amount of both mature and immature collagen 1 proteins was diminished by exposure of cells to DTT. Consistent with previous observations, a comparison of the percentage decrease in relative collagen amounts with and without PDGF showed that in most, but not all, cases the response was less when PDGF was added to the treatments ( Figure 8C ).
The stringent cutoff threshold used in the analysis has highlighted a robust set of key protein targets for future mechanistic studies of the molecular targets of reductants. The quantitative changes observed in our DIA dataset cannot be accounted for simply by DTT-induced changes to the mass of the peptides analysed (e.g. at cys residues), because there were no cys-containing peptides present in untreated cell lysates that were absent from reductant-exposed cell lysates; and because no differences were seen in the abundance of the majority of disulfide-containing proteins. Additionally, the relative levels of some ECM proteins, such as fibronectin and laminin, were not substantially decreased, further demonstrating that global translational attenuation in response to ER stress cannot account for the change seen in collagen abundance (Figure 8 ). Taken together, our data show that a subset of collagens in fibroblasts are sensitive to a reductive environment, raising the prospect that the ECM can be selectively targeted and manipulated by redox-based chemical approaches.
DISCUSSION
Our DIA data shows that the skin fibroblast proteome is surprisingly robust when the cells experience a chronic reductive stress, with a limited set of proteins decreasing in relative quantity. The induction of ER stress by DTT and other chemical agents classically results in recruitment of the BiP protein to exposed hydrophobic domains of unfolded ER proteins, releasing BiP from ER sensors such as Ire1α to facilitate the activation of XBP1 and selective induction of ER stress responsive gene transcription (5) . However, the ER stress response is both cell type and stressor specific, and is under temporal control (35) . In addition to gene transcription, translational regulation, microRNAs and degradative pathways can all alter the proteome profile (36) . A study by Cheng et. al. (37) showed that HeLa cells have very different transcriptional responses to a variety of stressors and downregulate the transcription of some collagen and ECM proteins in response to ER stress (38) . Cancer derived cell lines, such as HeLa, frequently heighten the expression of ER chaperones to provide a selective survival advantage, and may therefore be more sensitive to the induction of ER stress by chemical reagents.
A key question arising from our study is why some collagens appear particularly sensitive to reductive stress while other plasma membrane and disulfide-containing proteins are unaffected (Figures 3   and 8 ). One possibility is PDGFR pathway-driven remodelling. Collagens and other ECM molecules can bind to and sequester PDGF at the cell surface (39) . If so, sustained PDGFR pathway signalling, driven by a reductant, would trigger a feedback mechanism to decrease the level of collagens to alleviate PDGF signalling and restore cellular homeostasis. Consistent with this hypothesis, we found, from the proteomic analysis, that two peptidases involved in the degradation of the ECM (TIMP1 and TIMP3) are oppositely regulated in PDGF-stimulated cells exposed to DTT (Figure 3 ) and are candidates for restructuring the ECM of redox-challenged fibroblasts, modulating the apoptosis versus cell survival outcome. Collagens are likely to be more sensitive to redox stress than other proteins because they are subjected to intensive intracellular quality control, requiring disulfide bonds, glycosylation, propeptide processing, specialist packaging and export from the ER (through TANGO/cTAGE COPII exit sites), exocytosis and extracellular fibril formation, in addition to the hydroxylation of proline and lysine residues by prolyl hydroxylase and lysyl oxidase (LOX) respectively (2) . It was noteworthy that in our study, LOX was one of the 41 proteins that significantly decreased in the presence of DTT, suggesting that extracellular collagen assembly becomes limiting, resulting in the degradation of incompletely processed forms. This idea is supported by the western blotting data ( Figure 8B) showing that with DTT treatment, the levels of collagen α1(I) and α2(I) decline, without the accumulation of intermediate forms at steady-state. Overall, the data presented in this paper show that matrix remodelling and collagen deposition are under redoxresponsive control.
Another key question is how DTT stimulates the phosphorylation of Akt in the absence of PDGF ( Figures 5 and 6) . One possibility is that DTT partially reduces the PDGF receptor (or Raf/MEK kinases upstream of Akt) and causes a conformational change that triggers downstream signalling in the absence of growth factors. However, to date we have found no evidence of PDGFR autophosphorylation in cells subjected to DTT. A second possibility is that the reductive capacity of DTT modulates an Akt regulatory phosphatase such as PHLPP (40) , shifting the equilibrium of Akt to the phosphorylated state. It has been shown that the PDGFR pathway phosphatase SHP2 is regulated by reversible oxidation of a thiolate at the active site (41) and that PTP1B is also modulated in this way (42) . The PH domain of PHLPP has a number of cysteine residues that are potentially redox modifiable, and it will be interesting to determine whether this phosphatase becomes post-translationally altered after exposure to reductants. Future work to dissect the ERK/Akt signalling pathways in detail will be required to pinpoint the precise mechanism(s) of reductant induced phosphorylation and dephosphorylation. A key study published while this manuscript was in revision has proposed that ERK and Akt regulate an early step in the ER export of a subset of secreted proteins (43) The experiments demonstrating that DTT and other physiological reductants such as taurine ( Figure 7) ultimately result in dephosphorylation of MAPK suggest that a MAPK phosphatase such as mitogen-activated protein kinase phosphatase 1 or 3 (MKP-1/3) must be recruited to ERK1/2 during chronic reductive stress, but the mechanism is unknown. It is notable that Shc interacts directly with ERK to prevent ERK activation (44) . The Shc interaction loop contacting ERK contains a cysteine, thus it will be informative to determine whether this interaction is also redox-regulated and diminished by reductants.
Ultimately, it will be important to assess the dynamic phosphoproteome of fibroblasts exposed to reductive stress, to determine which phosphatase or phosphatases dephosphorylate ERK1/2, and to establish whether phosphatase inhibition makes cells more or less susceptible to oxidative stress-induced ageing.
In a study on lipopolysaccharide-induced cardiac dysfunction in mice, Dong et al. showed that chronic Akt activation can protect against apoptosis and ER stress (45) . Indeed, signalling through the MAPK/Akt pathway seen in our experiments did not result in cell death or senescence under short-term conditions of reductive stress ( Figure 6 and Supplementary Figure 3 ), despite the activation of an ER stress response through XBP1 (Figure 1 ). Instead, we found that acute DTT treatment significantly promoted the migration of PDGF-stimulated fibroblasts into a scratch-wound ( Supplementary Figure 4) .
Although a pleiotropic bulk reductant like DTT is not a suitable drug candidate, our data clearly show that targeted and specific redox active compounds have potential for application in wound healing, where two major factors are migration of cells into the wound to achieve wound closure (driven by the PDGFR signalling pathway) and the deposition of high quality ECM to avoid scarring and fibrosis (controlled in part by collagen remodelling). Our data is also supported by a skin aging study that showed that a subset of the secretory proteins that we have identified as sensitive to reductive stress are dysregulated in aged dermal fibroblast skin cell secretomes, including collagen I alpha chains, endosialin, carboxypeptidases and fibrillins (46) . Furthermore, of the top 20 proteins that we have uncovered as downregulated in fibroblasts upon exposure to reductants, 15 are dysregulated with age in a multi-decade and ethnicity study of the dermis (47) , demonstrating that our reductive stress approach has the capacity to reveal genes, proteins and pathways associated with biological processes in vivo.
An important finding from this study is that no significant changes to the amounts of downstream ER stress target proteins were identified by DIA analysis (Figures 3 and 4) , including the ER chaperones BiP and gp96 ( Figure 5B ). The fold changes seen for these chaperones at steady-state were 0.99 and 0.97 Our wide-ranging findings are also relevant to skin disorders such as scleroderma, an immunemediated condition characterised by massive fibrosis of the skin and other organs, which results in death through end-stage organ failure. Patients with scleroderma often generate excessive reactive oxygen species (50) and can be treated with imatinib mesylate (Gleevec), a tyrosine kinase inhibitor that inhibits TGFβ and PDGF signalling pathways. Imatinib prevents the development of inflammation-driven experimental fibrosis (51) . The potential for small molecule reductants to counter free radical generation in scleroderma merits further investigation, to evaluate whether the potentially protective effects of the redox signalling response outweigh the negative effects associated with ER and mitochondrial stress. It will be important to understand whether myofibroblasts from scar tissue respond in the same way to reductants as fibroblasts from other sites such as facial tissue, which derive from the neural crest. In particular, the decreased expression of Wnt5a that occurs in BJ fibroblasts exposed to DTT (Figures 3 and   4 ) also deserves attention: the Wnt/βcatenin pathway is required for hair follicle growth and can be targeted to reprogram ECM deposition in adult dermal fibroblasts (52), suggesting that bespoke redox reagents could be developed to influence ECM deposition in different fibroblast subpopulations. Taken together, the use of DIA technology has highlighted a small but exciting set of novel redox-regulated targets for further evaluation in skin tissue models. Percentage overrepresentation of GO biological process terms found to be statistically significantly overrepresented upon DTT treatment. Proteins were tested against a reference list of all quantified proteins in the data set using the PANTHER overrepresentation test (release 20171205) and PANTHER version 13.1 (release 2018-08-09). A Fisher's exact test with FDR multiple test correction was carried out using the GO biological process complete annotation set. For ease of viewing only the parent GO term is displayed and organ-specific terms have been removed. 
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